Increasing Access to HIV Counseling and Testing (VCT) and Enhancing HIV/AIDS Communications, Prevention, and Care in Botswana, Lesotho, South Africa, Swaziland and Cote d'Ivoire, 22870-22875 [05-8751]
Download as PDF
22870
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
Dated: April 26, 2005.
William P. Nichols,
Acting Director, Procurement and Grants
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–8749 Filed 5–2–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Increasing Access to HIV Counseling
and Testing (VCT) and Enhancing HIV/
AIDS Communications, Prevention,
and Care in Botswana, Lesotho, South
Africa, Swaziland and Cote d’Ivoire
Announcement Type: New.
Funding Opportunity Number:
AA006.
Catalog of Federal Domestic
Assistance Number: 93.067.
Key Dates:
Application Deadline: June 2, 2005.
I. Funding Opportunity Description
Authority: This program is authorized
under Sections 307 and 317(k)(2) of the
Public Health Service Act, [42 U.S.C.
Sections 242l and 247b(k)(2)], as amended.
Background
Southern Africa faces the world’s
most severe HIV/AIDS epidemic.
National prevalence rates are estimated
at 30 percent in Lesotho, 27.9 percent
(GOSA 2003 Antenatal Study) in South
Africa, 37 percent in Botswana, and 39
percent in Swaziland. Cote d’Ivoire has
the highest HIV prevalence in the West
African sub-region. Young adults are
among the hardest hit. The availability
of HIV counseling and testing (CT),
prevention communications and
interventions, and care varies in the five
countries; and, in all places, Voluntary
Counseling and Testing (VCT) needs
further promotion and strengthening. In
some of the countries, most people who
have been tested for HIV have been
tested for medical diagnostic purposes
or because they are pregnant, while in
Botswana, for example, a good VCT
service network exists but remains
underutilized. In all five countries,
stigma surrounding accessing HIV CT
services, fears of confidentiality not
being maintained, and low belief in the
efficacy of Rapid Test Kits remain
barriers to people accessing HIV CT.
Overall, relatively few asymptomatic
people are accessing VCT services that
would empower them to change their
behavior and direct them to post-test
care and support services, including
VerDate jul<14>2003
15:43 May 02, 2005
Jkt 205001
antiretroviral therapy (ART) and
Tuberculosis (TB) therapy.
Other aspects of behavior change need
strengthening as well. Levels of
abstinence, faithfulness, and correct and
consistent condom use need to increase
in all countries, in order to decrease HIV
incidence. Research has shown that key
mediating factors to infection, such as
alcohol and substance abuse and partner
violence, are also prevalent in the
populations at high risk for HIV
infection in the five countries; thus,
these mediating factors also need to be
addressed in prevention, care and
treatment efforts. Youth are particularly
vulnerable to infection, but also
particularly open to positive behavior
change; thus, the youth of these five
countries should be a key target group
for some of the activities proposed
below.
Purpose: The Centers for Disease
Control and Prevention (CDC)
announces the availability of fiscal year
(FY) 2005 funds up to $5.8 million for
a cooperative agreement program to
increase United States (U.S.) support for
Botswana, South Africa, Lesotho,
Swaziland and Cote d’Ivoire to limit the
further spread of HIV/AIDS and to care
for those affected by this devastating
disease. This funding is an action by the
U.S. Government recognizing the impact
that HIV/AIDS continues to have on
individuals, families, communities and
nations, and the need to do more. Over
the next five years, it is expected that
these activities will contribute to
achieving the global targets of the
United States President’s Emergency
Plan for AIDS Relief (PEPFAR). The
mission of the PEPFAR is to work with
leaders throughout the world to combat
HIV/AIDS, promoting integrated
prevention, treatment, and care
interventions, with an urgent focus on
countries that are among the most
afflicted nations of the world. The goals
are as follows:
• To encourage bold leadership at
every level to fight HIV/AIDS.
• Apply best practices within our
bilateral HIV/AIDS prevention,
treatment, and care programs, in concert
with the objectives and policies of the
host governments’ national HIV/AIDS
strategies.
• Encourage partners, including
multilateral organizations and other
host governments, to coordinate at all
levels to strengthen response efforts, to
embrace best practices, to adhere to
principles of sound management, and to
harmonize monitoring and evaluation
efforts to ensure the most effective and
efficient use of resources.
In the PEPFAR funded countries, the
targets are to: (1) Provide treatment to
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
two million HIV-infected people; (2)
prevent seven million new infections;
and (3) provide care to ten million
people infected and affected by HIV/
AIDS, including orphans and vulnerable
children.
The purpose of the program is to
increase the use of high quality HIV CT
services in Botswana, Lesotho, South
Africa, Swaziland and Core d’Ivoire.
Use of CT services is intended to lead
to safer sexual behaviors, including
abstinence, fidelity, and correct and
consistent condom use, and increased
use of care and support services through
a strong referral network to
complementary services. A secondary
purpose of this program is to enhance
HIV/AIDS prevention communications
activities.
Measurable outcomes of the program
will be in alignment with one or more
of the following performance goals for
the PEPFAR program:
Palliative Care—Counseling and Testing
(CT)
1. Number of CT service outlets/
programs, direct and/or indirect.
2. Number of clients receiving both
CT, direct.
3. Number of people trained in both
CT, direct.
Palliative Care—TB/HIV
• Number of people provided with
palliative care for TB/HIV, direct and/or
indirect.
Prevention—Abstinence and Be Faithful
(A/B)
• Number of community outreach
and/or mass media programs that are A/
B focused, direct and/or indirect.
• Number of people reached through
community outreach and/or mass media
programs that are not A/B focused.
Prevention—Other
• Number of community outreach
and/or mass media programs that are
not focused on A/B, direct and/or
indirect.
• Number of people reached through
community outreach and/or mass media
programs that are not A/B focused
Treatment—Laboratory Infrastructure
• Number of labs, direct.
• Number of people trained in lab
related activities, direct.
In addition, funds will support
necessary wrap-around activities to
complement HIV CT, such as prevention
communications, interventions, and
referrals and linkages to HIV/AIDS care.
Activities:
The specific activities carried out in
each country should meet the needs of
E:\FR\FM\03MYN1.SGM
03MYN1
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
that country; thus, the activity plans for
each country may differ under this
agreement. Awardee activities for this
program are as follows:
1. Establishing and running nonmedical, stand-alone HIV CT sites
linked together within countries as a
network sharing: standardized CT
protocols and procedures; standardized
management systems; standardized
monitoring and evaluation procedures
and instruments; and standardized
marketing and education materials and
activities.
2. Operating mobile HIV CT activities
to reach rural populations and/or
employees at their workplaces.
3. Developing and implementing
comprehensive social marketing
campaigns to create informed demand
for HIV CT services and reduce stigma
surrounding accessing CT.
4. Developing and implementing
comprehensive social marketing
campaigns to promote abstinence,
faithfulness, and/or consistent and
correct condom use.
5. Developing and implementing
programs to promote healthy behavior
change among high-risk populations
(e.g., youth) and at high-risk sites (e.g.,
bars, bottle shops).
6. Promoting messages that raise
awareness about the harmful ties
between alcohol/substance abuse and
HIV infection and poor adherence to
antiretrovirals (ARVs).
7. Creating referral networks for HIV
CT clients to improve access to care and
support services.
8. Collecting strategic information to
ensure the effectiveness of HIV/AIDS
prevention activities.
9. Providing support as appropriate to
the national Departments of Health
(DOH), Ministries of Health (MOH) and
other South African Government
agencies, which may include, without
limitation: improvement of monitoring
and evaluation activities to assure high
quality service delivery in all HIV CT
sites; development of communications
materials; development and/or
implementation of training curricula;
and improvement of laboratory
infrastructure.
10. Training faith-based leaders to
encourage testing and partnering with
CT providers to enable testing at places
of worship.
11. Ensuring that all of the above
activities are undertaken in a manner
consistent with and in support of U.S.
Government HIV/AIDS strategies.
In a cooperative agreement, CDC staff
is substantially involved in the program
activities, above and beyond routine
monitoring.
VerDate jul<14>2003
15:43 May 02, 2005
Jkt 205001
CDC Activities for this program are as
follows:
1. Providing input into overall
program strategies.
2. Providing technical assistance, as
needed, in the development of HIV CT
service provision, training, referral and
communications strategies and
activities. Technical assistance may be
provided directly by CDC staff or
through organizations supported by
CDC under a separate contract.
3. Collaborating with the awardee in
the development and implementation of
information gathering systems to enable
assessment of program activities.
4. Assisting, as needed, in the
monitoring and evaluation of the
program and the development of further
appropriate initiatives.
5. Fostering collaboration between the
awardee and other CDC and U.S.
Government-funded programs.
6. Providing oversight for the
program, including approval of key
personnel and annual operational plans.
II. Award Information
Type of Award: Cooperative
Agreement. CDC involvement in this
program is listed in the Activities
Section above.
Fiscal Year Funds: FY 2005.
Approximate Total Funding: $2–5.8
million per year, over five years; or $30
million. (This amount is an estimate,
and is subject to availability of funds.)
Approximate Number of Awards:
One.
Approximate Average Award: $1–2
million for South Africa, $1–2 million
for Swaziland and Lesotho, $1–2
million for Cote d’Ivoire and $400,000
for Botswana. (This amount is for the
first 12-month budget period, and
includes both direct and indirect costs.)
Floor of Award Range: $1 million.
Ceiling of Award Range: $6.5 million.
(This ceiling is for the first 12-month
budget period.)
Anticipated Award Date: July 1, 2005.
Budget Period Length: 12 months.
Project Period Length: Five years.
Throughout the project period, CDC’s
commitment to continuation of awards
will be conditioned on the availability
of funds, evidence of satisfactory
progress by the recipient (as
documented in required reports and
input from recipient government
agencies), and the determination that
continued funding is in the best interest
of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
PO 00000
Applications may be submitted by:
• Public nonprofit organizations
Frm 00031
Fmt 4703
Sfmt 4703
22871
• Private nonprofit organizations
• Universities
• Colleges
• For profit organizations
• Small, minority, women-owned
businesses
• Community-based organizations
• Research institutions
• Hospitals
• Faith-based organizations
Competition for this cooperative
agreement is limited to the types of
organizations listed above because of
the uniqueness the specific activities for
this project and the location of where
the majority of the work will be
performed, in multiple countries
throughout Africa. The types of
organizations listed above are those that
have direct experience with performing
this type of activity. CDC and the Global
AIDS Program have routinely
coordinated with the types of
organizations listed above for activities
similar to those proposed in this RFA
multiple times in the past.
The organizations listed below are
those that are excluded from
competition:
• Federally recognized Indian tribal
governments
• Indian tribes
• Indian tribal organizations
• State and local governments or their
Bona Fide Agents (this includes the
District of Columbia, the
Commonwealth of Puerto Rico, the
Virgin Islands, the Commonwealth of
the Northern Marianna Islands,
American Samoa, Guam, the Federated
States of Micronesia, the Republic of the
Marshall Islands, and the Republic of
Palau)
• Political subdivisions of States (in
consultation with States)
The organizations listed directly
above have been excluded from
competition because inherently they do
not have a mandate to, nor have the
resources, skills or experience to
provide the types of services that are
requested as part of this cooperative
agreement.
III.2. Cost Sharing or Matching
Matching funds are not required for
this program.
III.3. Other
If you request a funding amount
greater than the ceiling of the award
range, your application will be
considered non-responsive, and will not
be entered into the review process. You
will be notified that your application
did not meet the submission
requirements.
E:\FR\FM\03MYN1.SGM
03MYN1
22872
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
Special Requirements
If your application is incomplete or
non-responsive to the special
requirements listed in this section, it
will not be entered into the review
process. You will be notified that your
application did not meet submission
requirements.
Applicant must meet the following
criteria:
• Have at least three years of
documented HIV/AIDS related program
implementation experience in each of
the countries: Botswana, Lesotho, South
Africa, Swaziland and Cote d’Ivoire.
• Have demonstrated expertise in the
areas of direct HIV CT service delivery,
AIDS prevention communications, and
social marketing in Botswana, Lesotho,
South Africa, Swaziland and Cote
d’Ivoire.
• Be locally incorporated in
Botswana, Lesotho, South Africa,
Swaziland and Cote d’Ivoire.
• Have established relationships with
the government in all five countries and
written letters of support from the
National DOH or MOH in each country.
U.S. Embassy collaboration in
Swaziland and Lesotho will also be
necessary.
• Late applications will be considered
non-responsive. See section ‘‘IV.3.
Submission Dates and Times’’ for more
information on deadlines.
• Demonstrate non-profit 501(c)(3)
status.
• Provide Articles of Incorporation in
each country. Articles of Incorporation
are legal documents providing proof
that the organization is legally
incorporated in the specific country.
• Have documented HIV/AIDS
prevention activities in each country.
• Note: Title 2 of the United States
Code Section 1611 states that an
organization described in Section
501(c)(4) of the Internal Revenue Code
that engages in lobbying activities is not
eligible to receive Federal funds
constituting an award, grant, or loan.
IV. Application and Submission
Information
IV.1. Address To Request Application
Package
To apply for this funding opportunity
use application form PHS 5161–1.
CDC strongly encourages you to
submit your application electronically
by utilizing the forms and instructions
posted for this announcement at
https://www.grants.gov.
Application forms and instructions
are available on the CDC Web site, at the
following Internet address: https://
www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the
Internet, or if you have difficulty
VerDate jul<14>2003
15:43 May 02, 2005
Jkt 205001
accessing the forms on-line, you may
contact the CDC Procurement and
Grants Office Technical Information
Management Section (PGO–TIM) staff
at: 770–488–2700. Application forms
can be mailed to you.
IV.2. Content and Form of Submission
Application: You must submit a
project narrative with your application
forms. The narrative must be submitted
in the following format:
• Maximum number of pages: 35. If
your narrative exceeds the page limit,
only the first pages which are within the
page limit will be reviewed.
• Font size: 12 point unreduced
• Single spaced
• Paper size: 8.5 by 11 inches
• Page margin size: One inch
• Printed only on one side of page
• Held together only by rubber bands
or metal clips; not bound in any other
way.
• Must be submitted in English.
Your narrative should address
activities to be conducted over the
entire project period, and must include
the following items in the order listed:
• Project Context and Background
(Understanding and Need)
• Project Strategy—Description and
Methodologies
• Project Goals
• Project Outputs
• Project Contribution to PEPFAR
Goals and Objectives
• Workplan and Description of
Project Components and Activities
• Performance Measures
• Gantt Chart with Timeline
• Management of Project Funds and
Reporting
Additional information may be
included in the application appendices.
The appendices will not be counted
toward the narrative page limit. This
additional information includes:
• Project Budget
• Project Budget Notes
• Job Descriptions
• Testing Protocols
• Overview of HIV CT Quality
Assurance Procedures, Both Internal
and External
• HIV CT Quality Assurance,
Monitoring and Evaluation and Strategic
Information Forms
• HIV CT Referral Procedures and
Forms
• Mobile HIV CT Processes and
Procedures
• HIV CT Staff Training Curricula
• Applicant’s Corporate Capability
Statement
You are required to have a Dun and
Bradstreet Data Universal Numbering
System (DUNS) number to apply for a
grant or cooperative agreement from the
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Federal government. The DUNS number
is a nine-digit identification number,
which uniquely identifies business
entities. Obtaining a DUNS number is
easy and there is no charge. To obtain
a DUNS number, access https://
www.dunandbradstreet.com or call 1–
866–705–5711.
For more information, see the CDC
Web site at: https://www.cdc.gov/od/pgo/
funding/pubcommt.htm. If your
application form does not have a DUNS
number field, please write your DUNS
number at the top of the first page of
your application, and/or include your
DUNS number in your application cover
letter.
Additional requirements that may
require you to submit additional
documentation with your application
are listed in section ‘‘VI.2.
Administrative and National Policy
Requirements.’’
IV.3. Submission Dates and Times
Application Deadline Date: June 2,
2005. Explanation of Deadlines:
Applications must be received in the
CDC Procurement and Grants Office by
4 p.m. eastern time on the deadline
date.
You may submit your application
electronically at https://www.grants.gov.
Applications completed online through
Grants.gov are considered formally
submitted when the applicant
organization’s Authorizing Official
electronically submits the application to
https://www.grants.gov. Electronic
applications will be considered as
having met the deadline if the
application has been submitted
electronically by the applicant
organization’s Authorizing Official to
Grants.gov on or before the deadline
date and time.
If you submit your application
electronically with Grants.gov, your
application will be electronically time/
date stamped, which will serve as
receipt of submission. You will receive
an e-mail notice of receipt when CDC
receives the application.
If you submit your application by the
United States Postal Service or
commercial delivery service, you must
ensure that the carrier will be able to
guarantee delivery by the closing date
and time. If CDC receives your
submission after closing due to: (1)
Carrier error, when the carrier accepted
the package with a guarantee for
delivery by the closing date and time, or
(2) significant weather delays or natural
disasters, you will be given the
opportunity to submit documentation of
the carriers guarantee. If the
documentation verifies a carrier
problem, CDC will consider the
E:\FR\FM\03MYN1.SGM
03MYN1
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
submission as having been received by
the deadline.
If you submit a hard copy application,
CDC will not notify you upon receipt of
your submission. If you have a question
about the receipt of your LOI or
application, first contact your courier. If
you still have a question, contact the
PGO–TIM staff at: 770–488–2700. Before
calling, please wait two to three days
after the submission deadline. This will
allow time for submissions to be
processed and logged.
This announcement is the definitive
guide on LOI and application content,
submission address, and deadline. It
supersedes information provided in the
application instructions. If your
submission does not meet the deadline
above, it will not be eligible for review,
and will be discarded. You will be
notified that you did not meet the
submission requirements.
IV.4. Intergovernmental Review of
Applications
Executive Order 12372 does not apply
to this program.
IV.5. Funding Restrictions
Restrictions, which must be taken into
account while writing your budget, are
as follows:
• Funds may not be used for research.
• Reimbursement of pre-award costs
is not allowed.
• Funds may be spent for reasonable
program purposes, including personnel,
travel, supplies, and services.
Equipment may be purchased if deemed
necessary to accomplish program
objectives; however, prior approval by
CDC officials must be requested in
writing.
• All requests for funds contained in
the budget shall be stated in U.S.
dollars. Once an award is made, CDC
will not compensate foreign grantees for
currency exchange fluctuations through
the issuance of supplemental awards.
• The costs that are generally
allowable in grants to domestic
organizations are allowable to foreign
institutions and international
organizations, with the following
exception: With the exception of the
American University, Beirut, and the
World Health Organization, Indirect
Costs will not be paid (either directly or
through sub-award) to organizations
located outside the territorial limits of
the U.S. or to international
organizations regardless of their
location.
• The applicant may contract with
other organizations under this program;
however the applicant must perform a
substantial portion of the activities
(including program management and
VerDate jul<14>2003
15:43 May 02, 2005
Jkt 205001
operations, and delivery of prevention
services for which funds are required).
• You must obtain an annual audit of
these CDC funds (program-specific
audit) by a U.S.-based audit firm with
international branches and current
licensure/authority in-country, and in
accordance with International
Accounting Standards or equivalent
standards(s) approved in writing by
CDC.
• A fiscal Recipient Capability
Assessment may be required, prior to or
post award, in order to review the
applicant’s business management and
fiscal capabilities regarding the
handling of U.S. Federal funds.
• Prostitution and Related Activities
The U.S. Government is opposed to
prostitution and related activities,
which are inherently harmful and
dehumanizing, and contribute to the
phenomenon of trafficking in persons.
Any entity that receives, directly or
indirectly, U.S. Government funds in
connection with this document
(‘‘recipient’’) cannot use such U.S.
Government funds to promote or
advocate the legalization or practice of
prostitution or sex trafficking. Nothing
in the preceding sentence shall be
construed to preclude the provision to
individuals of palliative care, treatment,
or post-exposure pharmaceutical
prophylaxis, and necessary
pharmaceuticals and commodities,
including test kits, condoms, and, when
proven effective, microbicides. A
recipient that is otherwise eligible to
receive funds in connection with this
document to prevent, treat, or monitor
HIV/AIDS shall not be required to
endorse or utilize a multisectoral
approach to combating HIV/AIDS, or to
endorse, utilize, or participate in a
prevention method or treatment
program to which the recipient has a
religious or moral objection. Any
information provided by recipients
about the use of condoms as part of
projects or activities that are funded in
connection with this document shall be
medically accurate and shall include the
public health benefits and failure rates
of such use.
In addition, any recipient must have
a policy explicitly opposing prostitution
and sex trafficking. The preceding
sentence shall not apply to any ‘‘exempt
organizations’’ (defined as the Global
Fund to Fight AIDS, Tuberculosis and
Malaria, the World Health Organization,
the International AIDS Vaccine
Initiative or to any United Nations
agency), but does apply to any nongovernmental, non-exempt organization
entity receiving U.S. government funds
from an exempt organization in
connection with this document.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
22873
The following definition applies for
purposes of this clause:
• Sex trafficking means the
recruitment, harboring, transportation,
provision, or obtaining of a person for
the purpose of a commercial sex act. 22
U.S.C. 7102(9).
All recipients must insert provisions
implementing the applicable parts of
this section, ‘‘Prostitution and Related
Activities,’’ in all sub-agreements under
this award. These provisions must be
express terms and conditions of the subagreement, must acknowledge that
compliance with this section,
‘‘Prostitution and Related Activities,’’ is
a prerequisite to receipt and
expenditure of U.S. government funds
in connection with this document, and
must acknowledge that any violation of
the provisions shall be grounds for
unilateral termination of the agreement
prior to the end of its term. Recipients
must agree that HHS may, at any
reasonable time, inspect the documents
and materials maintained or prepared
by the recipient in the usual course of
its operations that relate to the
organization’s compliance with this
section, ‘‘Prostitution and Related
Activities.’’
All prime recipients receiving U.S.
Government funds (‘‘prime recipients’’)
in connection with this document must
certify compliance (pending OMB
clearance) prior to actual receipt of such
funds in a written statement referencing
this document (e.g., ‘‘[Prime recipient’s
name] certifies compliance with the
section, ‘‘Prostitution and Related
Activities.’’’’) addressed to the agency’s
grants officer. Such certifications by
prime recipients are prerequisites to the
payment of any U.S. Government funds
in connection with this document.
Recipients’ compliance with this
section, ‘‘Prostitution and Related
Activities,’’ is an express term and
condition of receiving U.S. government
funds in connection with this
document, and any violation of it shall
be grounds for unilateral termination by
HHS of the agreement with HHS in
connection with this document prior to
the end of its term. The recipient shall
refund to HHS the entire amount
furnished in connection with this
document in the event it is determined
by HHS that the recipient has not
complied with this section,
‘‘Prostitution and Related Activities.’’
If you are a U.S.-based organization
and are requesting indirect costs in your
budget, you must include a copy of your
indirect cost rate agreement. If your
indirect cost rate is a provisional rate,
the agreement should be less than 12
months of age.
E:\FR\FM\03MYN1.SGM
03MYN1
22874
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
Guidance for completing your budget
can be found on the CDC Web site, at
the following Internet address: https://
www.cdc.gov/od/pgo/funding/
budgetguide.htm.
IV.6. Other Submission Requirements
Application Submission Address
CDC strongly encourages applicants to
submit electronically at: https://
www.grants.gov. You will be able to
download a copy of the application
package from https://www.grants.gov,
complete it offline, and then upload and
submit the application via the
Grants.gov site. E-mail submissions will
not be accepted. If you are having
technical difficulties in Grants.gov, they
can be reached by E-mail at https://
www.support@grants.gov or by phone at
1–800–518–4726 (1–800–518-GRANTS).
The Customer Support Center is open
from 7 a.m. to 9 p.m. eastern time,
Monday through Friday.
CDC recommends that you submit
your application to Grants.gov early
enough to resolve any unanticipated
difficulties prior to the deadline. You
may also submit a back-up paper
submission of your application. Any
such paper submission must be received
in accordance with the requirements for
timely submission detailed in Section
IV.3. of the grant announcement. The
paper submission must be clearly
marked: ‘‘BACK-UP FOR ELECTRONIC
SUBMISSION. ’’ The paper submission
must conform to all requirements for
non-electronic submissions. If both
electronic and back-up paper
submissions are received by the
deadline, the electronic version will be
considered the official submission.
It is strongly recommended that you
submit your grant application using
Microsoft Office products (e.g.,
Microsoft Word, Microsoft Excel, etc.). If
you do not have access to Microsoft
Office products, you may submit a PDF
file. Directions for creating PDF files can
be found on the Grants.gov Web site.
Use of file formats other than Microsoft
Office or PDF may result in your file
being unreadable by our staff.
OR
Submit the original and two hard
copies of your application by mail or
express delivery service to: Technical
Information Management—AA006, CDC
Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341.
cooperative agreement. Measures of
effectiveness must relate to the
performance goals stated in the
‘‘Purpose’’ section of this
announcement. Measures must be
objective and quantitative, and must
measure the intended outcome. These
measures of effectiveness must be
submitted with the application and will
be an element of evaluation.
Your application will be evaluated
against the following criteria:
1. Ability to carry out the proposal (30
points): Does the applicant demonstrate
the experience and capability to achieve
the goals of the project?
2. Understanding the issues,
principles and systems requirements
involved in carrying out the project (30
points): Does the applicant demonstrate
an understanding of the issues,
principles and systems requirements to
carry out the project?
3. Work Plan (20 points): Does the
applicant describe activities that are
realistic, achievable and appropriate to
achieve the goals of the program?
4. Administrative and Accounting
Plan (20 points): Is there a plan to
prepare reports, monitor and evaluate
activities, audit expenditures and
manage the resources of the program?
5. Budget (not scored): Is the budget
for conducting the program itemized,
well-justified and consistent with
planned program activities?
V.2. Review and Selection Process
Applications will be reviewed for
completeness by the Procurement and
Grants Office (PGO) staff, and for
responsiveness by the National Center
for HIV, STD, and TB Prevention
(NCHSTP). Incomplete applications and
applications that are non-responsive to
the eligibility criteria will not advance
through the review process. Applicants
will be notified that their application
did not meet submission requirements.
An objective review panel will
evaluate complete and responsive
applications according to the criteria
listed in the ‘‘V.1. Criteria’’ section
above. Applications will be funded in
order by score and rank determined by
the review panel. All persons serving on
the panel will be external to NCHSTP.
CDC will provide justification for any
decision to fund out of rank order.
V.3. Anticipated Announcement and
Award Dates
V. Application Review Information
July 1, 2005.
V.1. Criteria
Applicants are required to provide
measures of effectiveness that will
demonstrate the accomplishment of the
various identified objectives of the
VerDate jul<14>2003
15:43 May 02, 2005
Jkt 205001
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a
Notice of Award (NoA) from the CDC
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Procurement and Grants Office. The
NoA shall be the only binding,
authorizing document between the
recipient and CDC. The NoA will be
signed by an authorized Grants
Management Officer, and mailed to the
recipient fiscal officer identified in the
application.
Unsuccessful applicants will receive
notification of the results of the
application review by mail.
VI.2. Administrative and National
Policy Requirements
45 CFR Part 74 and Part 92
For more information on the Code of
Federal Regulations, see the National
Archives and Records Administration at
the following Internet address: https://
www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.
The following additional
requirements apply to this project:
• AR–4 HIV/AIDS Confidentiality
Provisions
• AR–6 Patient Care
• AR–10 Smoke-Free Workplace
Requirements
• AR–12 Lobbying Restrictions
• AR–15 Proof of Non-Profit Status
• AR–25 Release and Sharing of
Data
Additional information on these
requirements can be found on the CDC
Web site at the following Internet
address: https://www.cdc.gov/od/pgo/
funding/ARs.htm.
An additional Certifications form
from the PHS 5161–1 application needs
to be included in your Grants.gov
electronic submission only. Refer to
https://www.cdc.gov/od/pgo/funding/
PHS5161–1Certificates.pdf. Once the
form is filled out, attach it to your
Grants.gov submission as Other
Attachment Forms.
VI.3. Reporting Requirements
You must provide CDC with an
original, plus two hard copies of the
following reports:
1. Interim progress report, due no less
than 90 days before the end of the
budget period. The progress report will
serve as your non-competing
continuation application, and must
contain the following elements:
a. Current Budget Period Activities
Objectives.
b. Current Budget Period Financial
Progress.
c. New Budget Period Program
Proposed Activity Objectives.
d. Budget.
e. Measures of Effectiveness.
f. Additional Requested Information.
2. Annual progress report, due 30
days after the end of the budget period.
E:\FR\FM\03MYN1.SGM
03MYN1
Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
3. Financial status report, due no
more than 90 days after the end of the
budget period.
4. Final financial and performance
reports, due no more than 90 days after
the end of the project period.
These reports must be mailed to the
Grants Management or Contract
Specialist listed in the ‘‘Agency
Contacts’’ section of this announcement.
VII. Agency Contacts
We encourage inquiries concerning
this announcement.
For general questions, contact:
Technical Information Management
Section, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta,
GA 30341, Telephone: 770–488–2700.
For program technical assistance,
contact: Mary Wettrich, Project Officer,
HHS/CDC Global AIDS Program, 9300
Pretoria Place, Washington, DC 20521–
9300, Telephone: 27 12 346 0170, Email: wettrichm@sacdc.co.za.
For financial, grants management, or
budget assistance, contact: Shirley
Wynn, Contract Specialist, CDC
Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341,
Telephone: 770–488–1515, E-mail:
zbx6@cdc.gov.
VIII. Other Information
This and other CDC funding
opportunity announcements can be
found on the CDC Web site, Internet
address: https://www.cdc.gov. Click on
‘‘Funding’’ then ‘‘Grants and
Cooperative Agreements.’’
Dated: April 26, 2005.
William P. Nichols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–8751 Filed 5–2–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Request for Application (RFA) 05069]
Administrative and Technical Support
for HIV Laboratory Activities in Brazil
and Other Lusophone-Speaking
Countries; Notice of Intent To Fund
Single Eligibility Award
A. Purpose
The Centers for Disease Control and
Prevention (CDC) announces the intent
to fund fiscal year (FY) 2005 funds for
a cooperative agreement program to: (1)
provide administrative and technical
support for HIV laboratory activities to
VerDate jul<14>2003
16:54 May 02, 2005
Jkt 205001
the Brazilian National AIDS Program;
and (2) to coordinate and implement
new and ongoing laboratory activities
initiated through the South-to-South
Regional Collaboration, through which
Brazil provides HIV technical assistance
to Lusophone-speaking African
countries. The purpose of the program
is to build the capacity of the Ministry
of Health (MOH) of Brazil in HIV
laboratory technology for improved
diagnosis and treatment of HIV/AIDS,
and to provide technical expertise from
Brazil to other Lusophone-speaking
countries. The Catalog of Federal
Domestic Assistance number for this
program is 93.067.
B. Eligible Applicant
Applications will only be solicited
from the Fundacao Universataria Jose
¸˜
Bonifacio (FUJB) [The Jose Bonifacio
University Foundation of the Federal
University of Rio de Janeiro], a private,
non-profit foundation, dedicated to
serving the interests of society in the
areas of education, research, and
extension, insofar as the Federal
University of Rio de Janeiro (UFRJ)
performs these activities. The FUJB is
empowered to manage contracts and
agreements drawn up for the support of
research projects and services executed
by the University, and to assist in the
maintenance of University activities in
the National and international arenas.
UFRJ has state of the art research/
clinical laboratory facilities and has the
only laboratory in Brazil with laboratory
staff highly-specialized in advanced
molecular biology and HIV serology
techniques for HIV/AIDS diagnostics.
UFRJ has longstanding experience and a
tradition of training technicians in these
technologies, domestically, regionally
(Latin America and the Caribbean), and
internationally. UFRJ personnel have
been subcontracted for the past year to
serve as laboratory consultants in both
Mozambique and Angola through the
CDC Global AIDS Program (GAP)
Brazil’s cooperative agreement with
Fundacao Oswaldo Cruz (FIOCRUZ), as
¸˜
part of the USG South-to-South
Collaboration. Increased demand for
trainings in these specialized areas has
prompted CDC GAP Brazil to develop
an agreement with the UFRJ’s
Foundation to formalize these trainings
as USG South-to-South Collaboration
activities. As the management body for
UFRJ, the Fundacao Universataria Jose
¸˜
Bonifacio is the only organization with
the capability to administer and manage
UFRJ laboratory research and training
activities.
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
22875
C. Funding
Approximately $75,000 is availble in
FY 2005 to fund this award. It is
expected that the award will begin on or
before July 1, 2005, and will be made for
a 12-month budget period within a
project period of up to 3 years. Funding
estimates may change.
D. Where To Obtain Additional
Information
For general comments or questions
about this announcement, contact:
Technical Information Management,
CDC Procurement and Grants Office,
2920 Bradywine Road, Atlanta, GA
30341–4146, Telephone: 770–488–2700.
For program technical assistance,
contact: William Brady, Project Officer,
CDC–AIDS, Unit 3500, APO AA, 34030,
Telephone: 55–61–273–4851, E-mail:
web0@cdc.gov.
For financial, grants management, or
budget assistance, contact: Shirley
Wynn, Contract Specialist, CDC
Procurement and Grants Office, 2920
Bradywine Road, Atlanta, GA 30341,
Telephone: 770–488–1515, E-mail:
zbx6@cdc.gov.
Dated: April 26, 2005.
William P. Nicols,
Director, Procurement and Grants Office,
Centers for Disease Control and Prevention.
[FR Doc. 05–8754 Filed 5–2–05; 8:45 am]
BILLING CODE 4163–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Expansion and Support of HIV/AIDS/
STI/TB Information, Education, and
Communication and Behavioral
Change Communication Activities in
Ethiopia
Announcement Type: New.
Funding Opportunity Number: RFA
05075.
Catalog of Federal Domestic
Assistance Number: 93.067.
Key Dates: Application Deadline: June
2, 2005.
I. Funding Opportunity Description
Authority: This program is authorized
under Sections 307 and 317(k)(2) of the
Public Health Service Act, [42 U.S.C.
Sections 242l and 247b(k)(2)], as amended,
and under Pub. L. 108–25 (United States
Leadership Against HIV/AIDS, Tuberculosis
and Malaria Act of 2003) [22 U.S.C. 7601].
Purpose: The purpose of this program
is to improve Human Immunodeficiency
Virus/Acquired Immunodeficiency
Syndrome/Sexually Transmitted
E:\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 70, Number 84 (Tuesday, May 3, 2005)]
[Notices]
[Pages 22870-22875]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Increasing Access to HIV Counseling and Testing (VCT) and
Enhancing HIV/AIDS Communications, Prevention, and Care in Botswana,
Lesotho, South Africa, Swaziland and Cote d'Ivoire
Announcement Type: New.
Funding Opportunity Number: AA006.
Catalog of Federal Domestic Assistance Number: 93.067.
Key Dates:
Application Deadline: June 2, 2005.
I. Funding Opportunity Description
Authority: This program is authorized under Sections 307 and
317(k)(2) of the Public Health Service Act, [42 U.S.C. Sections 242l
and 247b(k)(2)], as amended.
Background
Southern Africa faces the world's most severe HIV/AIDS epidemic.
National prevalence rates are estimated at 30 percent in Lesotho, 27.9
percent (GOSA 2003 Antenatal Study) in South Africa, 37 percent in
Botswana, and 39 percent in Swaziland. Cote d'Ivoire has the highest
HIV prevalence in the West African sub-region. Young adults are among
the hardest hit. The availability of HIV counseling and testing (CT),
prevention communications and interventions, and care varies in the
five countries; and, in all places, Voluntary Counseling and Testing
(VCT) needs further promotion and strengthening. In some of the
countries, most people who have been tested for HIV have been tested
for medical diagnostic purposes or because they are pregnant, while in
Botswana, for example, a good VCT service network exists but remains
underutilized. In all five countries, stigma surrounding accessing HIV
CT services, fears of confidentiality not being maintained, and low
belief in the efficacy of Rapid Test Kits remain barriers to people
accessing HIV CT. Overall, relatively few asymptomatic people are
accessing VCT services that would empower them to change their behavior
and direct them to post-test care and support services, including
antiretroviral therapy (ART) and Tuberculosis (TB) therapy.
Other aspects of behavior change need strengthening as well. Levels
of abstinence, faithfulness, and correct and consistent condom use need
to increase in all countries, in order to decrease HIV incidence.
Research has shown that key mediating factors to infection, such as
alcohol and substance abuse and partner violence, are also prevalent in
the populations at high risk for HIV infection in the five countries;
thus, these mediating factors also need to be addressed in prevention,
care and treatment efforts. Youth are particularly vulnerable to
infection, but also particularly open to positive behavior change;
thus, the youth of these five countries should be a key target group
for some of the activities proposed below.
Purpose: The Centers for Disease Control and Prevention (CDC)
announces the availability of fiscal year (FY) 2005 funds up to $5.8
million for a cooperative agreement program to increase United States
(U.S.) support for Botswana, South Africa, Lesotho, Swaziland and Cote
d'Ivoire to limit the further spread of HIV/AIDS and to care for those
affected by this devastating disease. This funding is an action by the
U.S. Government recognizing the impact that HIV/AIDS continues to have
on individuals, families, communities and nations, and the need to do
more. Over the next five years, it is expected that these activities
will contribute to achieving the global targets of the United States
President's Emergency Plan for AIDS Relief (PEPFAR). The mission of the
PEPFAR is to work with leaders throughout the world to combat HIV/AIDS,
promoting integrated prevention, treatment, and care interventions,
with an urgent focus on countries that are among the most afflicted
nations of the world. The goals are as follows:
To encourage bold leadership at every level to fight HIV/
AIDS.
Apply best practices within our bilateral HIV/AIDS
prevention, treatment, and care programs, in concert with the
objectives and policies of the host governments' national HIV/AIDS
strategies.
Encourage partners, including multilateral organizations
and other host governments, to coordinate at all levels to strengthen
response efforts, to embrace best practices, to adhere to principles of
sound management, and to harmonize monitoring and evaluation efforts to
ensure the most effective and efficient use of resources.
In the PEPFAR funded countries, the targets are to: (1) Provide
treatment to two million HIV-infected people; (2) prevent seven million
new infections; and (3) provide care to ten million people infected and
affected by HIV/AIDS, including orphans and vulnerable children.
The purpose of the program is to increase the use of high quality
HIV CT services in Botswana, Lesotho, South Africa, Swaziland and Core
d'Ivoire. Use of CT services is intended to lead to safer sexual
behaviors, including abstinence, fidelity, and correct and consistent
condom use, and increased use of care and support services through a
strong referral network to complementary services. A secondary purpose
of this program is to enhance HIV/AIDS prevention communications
activities.
Measurable outcomes of the program will be in alignment with one or
more of the following performance goals for the PEPFAR program:
Palliative Care--Counseling and Testing (CT)
1. Number of CT service outlets/programs, direct and/or indirect.
2. Number of clients receiving both CT, direct.
3. Number of people trained in both CT, direct.
Palliative Care--TB/HIV
Number of people provided with palliative care for TB/HIV,
direct and/or indirect.
Prevention--Abstinence and Be Faithful (A/B)
Number of community outreach and/or mass media programs
that are A/B focused, direct and/or indirect.
Number of people reached through community outreach and/or
mass media programs that are not A/B focused.
Prevention--Other
Number of community outreach and/or mass media programs
that are not focused on A/B, direct and/or indirect.
Number of people reached through community outreach and/or
mass media programs that are not A/B focused
Treatment--Laboratory Infrastructure
Number of labs, direct.
Number of people trained in lab related activities,
direct.
In addition, funds will support necessary wrap-around activities to
complement HIV CT, such as prevention communications, interventions,
and referrals and linkages to HIV/AIDS care.
Activities:
The specific activities carried out in each country should meet the
needs of
[[Page 22871]]
that country; thus, the activity plans for each country may differ
under this agreement. Awardee activities for this program are as
follows:
1. Establishing and running non-medical, stand-alone HIV CT sites
linked together within countries as a network sharing: standardized CT
protocols and procedures; standardized management systems; standardized
monitoring and evaluation procedures and instruments; and standardized
marketing and education materials and activities.
2. Operating mobile HIV CT activities to reach rural populations
and/or employees at their workplaces.
3. Developing and implementing comprehensive social marketing
campaigns to create informed demand for HIV CT services and reduce
stigma surrounding accessing CT.
4. Developing and implementing comprehensive social marketing
campaigns to promote abstinence, faithfulness, and/or consistent and
correct condom use.
5. Developing and implementing programs to promote healthy behavior
change among high-risk populations (e.g., youth) and at high-risk sites
(e.g., bars, bottle shops).
6. Promoting messages that raise awareness about the harmful ties
between alcohol/substance abuse and HIV infection and poor adherence to
antiretrovirals (ARVs).
7. Creating referral networks for HIV CT clients to improve access
to care and support services.
8. Collecting strategic information to ensure the effectiveness of
HIV/AIDS prevention activities.
9. Providing support as appropriate to the national Departments of
Health (DOH), Ministries of Health (MOH) and other South African
Government agencies, which may include, without limitation: improvement
of monitoring and evaluation activities to assure high quality service
delivery in all HIV CT sites; development of communications materials;
development and/or implementation of training curricula; and
improvement of laboratory infrastructure.
10. Training faith-based leaders to encourage testing and
partnering with CT providers to enable testing at places of worship.
11. Ensuring that all of the above activities are undertaken in a
manner consistent with and in support of U.S. Government HIV/AIDS
strategies.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine monitoring.
CDC Activities for this program are as follows:
1. Providing input into overall program strategies.
2. Providing technical assistance, as needed, in the development of
HIV CT service provision, training, referral and communications
strategies and activities. Technical assistance may be provided
directly by CDC staff or through organizations supported by CDC under a
separate contract.
3. Collaborating with the awardee in the development and
implementation of information gathering systems to enable assessment of
program activities.
4. Assisting, as needed, in the monitoring and evaluation of the
program and the development of further appropriate initiatives.
5. Fostering collaboration between the awardee and other CDC and
U.S. Government-funded programs.
6. Providing oversight for the program, including approval of key
personnel and annual operational plans.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: FY 2005.
Approximate Total Funding: $2-5.8 million per year, over five
years; or $30 million. (This amount is an estimate, and is subject to
availability of funds.)
Approximate Number of Awards: One.
Approximate Average Award: $1-2 million for South Africa, $1-2
million for Swaziland and Lesotho, $1-2 million for Cote d'Ivoire and
$400,000 for Botswana. (This amount is for the first 12-month budget
period, and includes both direct and indirect costs.)
Floor of Award Range: $1 million.
Ceiling of Award Range: $6.5 million. (This ceiling is for the
first 12-month budget period.)
Anticipated Award Date: July 1, 2005.
Budget Period Length: 12 months.
Project Period Length: Five years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports and input from recipient government agencies), and the
determination that continued funding is in the best interest of the
Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by:
Public nonprofit organizations
Private nonprofit organizations
Universities
Colleges
For profit organizations
Small, minority, women-owned businesses
Community-based organizations
Research institutions
Hospitals
Faith-based organizations
Competition for this cooperative agreement is limited to the types
of organizations listed above because of the uniqueness the specific
activities for this project and the location of where the majority of
the work will be performed, in multiple countries throughout Africa.
The types of organizations listed above are those that have direct
experience with performing this type of activity. CDC and the Global
AIDS Program have routinely coordinated with the types of organizations
listed above for activities similar to those proposed in this RFA
multiple times in the past.
The organizations listed below are those that are excluded from
competition:
Federally recognized Indian tribal governments
Indian tribes
Indian tribal organizations
State and local governments or their Bona Fide Agents
(this includes the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, the Commonwealth of the Northern Marianna
Islands, American Samoa, Guam, the Federated States of Micronesia, the
Republic of the Marshall Islands, and the Republic of Palau)
Political subdivisions of States (in consultation with
States)
The organizations listed directly above have been excluded from
competition because inherently they do not have a mandate to, nor have
the resources, skills or experience to provide the types of services
that are requested as part of this cooperative agreement.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be considered non-responsive, and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
[[Page 22872]]
Special Requirements
If your application is incomplete or non-responsive to the special
requirements listed in this section, it will not be entered into the
review process. You will be notified that your application did not meet
submission requirements.
Applicant must meet the following criteria:
Have at least three years of documented HIV/AIDS related
program implementation experience in each of the countries: Botswana,
Lesotho, South Africa, Swaziland and Cote d'Ivoire.
Have demonstrated expertise in the areas of direct HIV CT
service delivery, AIDS prevention communications, and social marketing
in Botswana, Lesotho, South Africa, Swaziland and Cote d'Ivoire.
Be locally incorporated in Botswana, Lesotho, South
Africa, Swaziland and Cote d'Ivoire.
Have established relationships with the government in all
five countries and written letters of support from the National DOH or
MOH in each country. U.S. Embassy collaboration in Swaziland and
Lesotho will also be necessary.
Late applications will be considered non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
Demonstrate non-profit 501(c)(3) status.
Provide Articles of Incorporation in each country.
Articles of Incorporation are legal documents providing proof that the
organization is legally incorporated in the specific country.
Have documented HIV/AIDS prevention activities in each
country.
Note: Title 2 of the United States Code Section 1611
states that an organization described in Section 501(c)(4) of the
Internal Revenue Code that engages in lobbying activities is not
eligible to receive Federal funds constituting an award, grant, or
loan.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161-1.
CDC strongly encourages you to submit your application
electronically by utilizing the forms and instructions posted for this
announcement at https://www.grants.gov.
Application forms and instructions are available on the CDC Web
site, at the following Internet address: https://www.cdc.gov/od/pgo/
forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 35. If your narrative exceeds the
page limit, only the first pages which are within the page limit will
be reviewed.
Font size: 12 point unreduced
Single spaced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Printed only on one side of page
Held together only by rubber bands or metal clips; not
bound in any other way.
Must be submitted in English.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed:
Project Context and Background (Understanding and Need)
Project Strategy--Description and Methodologies
Project Goals
Project Outputs
Project Contribution to PEPFAR Goals and Objectives
Workplan and Description of Project Components and
Activities
Performance Measures
Gantt Chart with Timeline
Management of Project Funds and Reporting
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes:
Project Budget
Project Budget Notes
Job Descriptions
Testing Protocols
Overview of HIV CT Quality Assurance Procedures, Both
Internal and External
HIV CT Quality Assurance, Monitoring and Evaluation and
Strategic Information Forms
HIV CT Referral Procedures and Forms
Mobile HIV CT Processes and Procedures
HIV CT Staff Training Curricula
Applicant's Corporate Capability Statement
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access https://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC Web site at: https://www.cdc.gov/
od/pgo/funding/pubcommt.htm. If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
Application Deadline Date: June 2, 2005. Explanation of Deadlines:
Applications must be received in the CDC Procurement and Grants Office
by 4 p.m. eastern time on the deadline date.
You may submit your application electronically at https://
www.grants.gov. Applications completed online through Grants.gov are
considered formally submitted when the applicant organization's
Authorizing Official electronically submits the application to https://
www.grants.gov. Electronic applications will be considered as having
met the deadline if the application has been submitted electronically
by the applicant organization's Authorizing Official to Grants.gov on
or before the deadline date and time.
If you submit your application electronically with Grants.gov, your
application will be electronically time/date stamped, which will serve
as receipt of submission. You will receive an e-mail notice of receipt
when CDC receives the application.
If you submit your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery by the closing date and time. If CDC
receives your submission after closing due to: (1) Carrier error, when
the carrier accepted the package with a guarantee for delivery by the
closing date and time, or (2) significant weather delays or natural
disasters, you will be given the opportunity to submit documentation of
the carriers guarantee. If the documentation verifies a carrier
problem, CDC will consider the
[[Page 22873]]
submission as having been received by the deadline.
If you submit a hard copy application, CDC will not notify you upon
receipt of your submission. If you have a question about the receipt of
your LOI or application, first contact your courier. If you still have
a question, contact the PGO-TIM staff at: 770-488-2700. Before calling,
please wait two to three days after the submission deadline. This will
allow time for submissions to be processed and logged.
This announcement is the definitive guide on LOI and application
content, submission address, and deadline. It supersedes information
provided in the application instructions. If your submission does not
meet the deadline above, it will not be eligible for review, and will
be discarded. You will be notified that you did not meet the submission
requirements.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may not be used for research.
Reimbursement of pre-award costs is not allowed.
Funds may be spent for reasonable program purposes,
including personnel, travel, supplies, and services. Equipment may be
purchased if deemed necessary to accomplish program objectives;
however, prior approval by CDC officials must be requested in writing.
All requests for funds contained in the budget shall be
stated in U.S. dollars. Once an award is made, CDC will not compensate
foreign grantees for currency exchange fluctuations through the
issuance of supplemental awards.
The costs that are generally allowable in grants to
domestic organizations are allowable to foreign institutions and
international organizations, with the following exception: With the
exception of the American University, Beirut, and the World Health
Organization, Indirect Costs will not be paid (either directly or
through sub-award) to organizations located outside the territorial
limits of the U.S. or to international organizations regardless of
their location.
The applicant may contract with other organizations under
this program; however the applicant must perform a substantial portion
of the activities (including program management and operations, and
delivery of prevention services for which funds are required).
You must obtain an annual audit of these CDC funds
(program-specific audit) by a U.S.-based audit firm with international
branches and current licensure/authority in-country, and in accordance
with International Accounting Standards or equivalent standards(s)
approved in writing by CDC.
A fiscal Recipient Capability Assessment may be required,
prior to or post award, in order to review the applicant's business
management and fiscal capabilities regarding the handling of U.S.
Federal funds.
Prostitution and Related Activities
The U.S. Government is opposed to prostitution and related
activities, which are inherently harmful and dehumanizing, and
contribute to the phenomenon of trafficking in persons.
Any entity that receives, directly or indirectly, U.S. Government
funds in connection with this document (``recipient'') cannot use such
U.S. Government funds to promote or advocate the legalization or
practice of prostitution or sex trafficking. Nothing in the preceding
sentence shall be construed to preclude the provision to individuals of
palliative care, treatment, or post-exposure pharmaceutical
prophylaxis, and necessary pharmaceuticals and commodities, including
test kits, condoms, and, when proven effective, microbicides. A
recipient that is otherwise eligible to receive funds in connection
with this document to prevent, treat, or monitor HIV/AIDS shall not be
required to endorse or utilize a multisectoral approach to combating
HIV/AIDS, or to endorse, utilize, or participate in a prevention method
or treatment program to which the recipient has a religious or moral
objection. Any information provided by recipients about the use of
condoms as part of projects or activities that are funded in connection
with this document shall be medically accurate and shall include the
public health benefits and failure rates of such use.
In addition, any recipient must have a policy explicitly opposing
prostitution and sex trafficking. The preceding sentence shall not
apply to any ``exempt organizations'' (defined as the Global Fund to
Fight AIDS, Tuberculosis and Malaria, the World Health Organization,
the International AIDS Vaccine Initiative or to any United Nations
agency), but does apply to any non-governmental, non-exempt
organization entity receiving U.S. government funds from an exempt
organization in connection with this document.
The following definition applies for purposes of this clause:
Sex trafficking means the recruitment, harboring,
transportation, provision, or obtaining of a person for the purpose of
a commercial sex act. 22 U.S.C. 7102(9).
All recipients must insert provisions implementing the applicable
parts of this section, ``Prostitution and Related Activities,'' in all
sub-agreements under this award. These provisions must be express terms
and conditions of the sub-agreement, must acknowledge that compliance
with this section, ``Prostitution and Related Activities,'' is a
prerequisite to receipt and expenditure of U.S. government funds in
connection with this document, and must acknowledge that any violation
of the provisions shall be grounds for unilateral termination of the
agreement prior to the end of its term. Recipients must agree that HHS
may, at any reasonable time, inspect the documents and materials
maintained or prepared by the recipient in the usual course of its
operations that relate to the organization's compliance with this
section, ``Prostitution and Related Activities.''
All prime recipients receiving U.S. Government funds (``prime
recipients'') in connection with this document must certify compliance
(pending OMB clearance) prior to actual receipt of such funds in a
written statement referencing this document (e.g., ``[Prime recipient's
name] certifies compliance with the section, ``Prostitution and Related
Activities.'''') addressed to the agency's grants officer. Such
certifications by prime recipients are prerequisites to the payment of
any U.S. Government funds in connection with this document.
Recipients' compliance with this section, ``Prostitution and
Related Activities,'' is an express term and condition of receiving
U.S. government funds in connection with this document, and any
violation of it shall be grounds for unilateral termination by HHS of
the agreement with HHS in connection with this document prior to the
end of its term. The recipient shall refund to HHS the entire amount
furnished in connection with this document in the event it is
determined by HHS that the recipient has not complied with this
section, ``Prostitution and Related Activities.''
If you are a U.S.-based organization and are requesting indirect
costs in your budget, you must include a copy of your indirect cost
rate agreement. If your indirect cost rate is a provisional rate, the
agreement should be less than 12 months of age.
[[Page 22874]]
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: https://www.cdc.gov/od/pgo/
funding/budgetguide.htm.
IV.6. Other Submission Requirements
Application Submission Address
CDC strongly encourages applicants to submit electronically at:
https://www.grants.gov. You will be able to download a copy of the
application package from https://www.grants.gov, complete it offline,
and then upload and submit the application via the Grants.gov site. E-
mail submissions will not be accepted. If you are having technical
difficulties in Grants.gov, they can be reached by E-mail at https://
www.support@grants.gov">www.support@grants.gov or by phone at 1-800-518-4726 (1-800-518-
GRANTS). The Customer Support Center is open from 7 a.m. to 9 p.m.
eastern time, Monday through Friday.
CDC recommends that you submit your application to Grants.gov early
enough to resolve any unanticipated difficulties prior to the deadline.
You may also submit a back-up paper submission of your application. Any
such paper submission must be received in accordance with the
requirements for timely submission detailed in Section IV.3. of the
grant announcement. The paper submission must be clearly marked:
``BACK-UP FOR ELECTRONIC SUBMISSION. '' The paper submission must
conform to all requirements for non-electronic submissions. If both
electronic and back-up paper submissions are received by the deadline,
the electronic version will be considered the official submission.
It is strongly recommended that you submit your grant application
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel,
etc.). If you do not have access to Microsoft Office products, you may
submit a PDF file. Directions for creating PDF files can be found on
the Grants.gov Web site. Use of file formats other than Microsoft
Office or PDF may result in your file being unreadable by our staff.
OR
Submit the original and two hard copies of your application by mail
or express delivery service to: Technical Information Management--
AA006, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341.
V. Application Review Information
V.1. Criteria
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the ``Purpose'' section of
this announcement. Measures must be objective and quantitative, and
must measure the intended outcome. These measures of effectiveness must
be submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
1. Ability to carry out the proposal (30 points): Does the
applicant demonstrate the experience and capability to achieve the
goals of the project?
2. Understanding the issues, principles and systems requirements
involved in carrying out the project (30 points): Does the applicant
demonstrate an understanding of the issues, principles and systems
requirements to carry out the project?
3. Work Plan (20 points): Does the applicant describe activities
that are realistic, achievable and appropriate to achieve the goals of
the program?
4. Administrative and Accounting Plan (20 points): Is there a plan
to prepare reports, monitor and evaluate activities, audit expenditures
and manage the resources of the program?
5. Budget (not scored): Is the budget for conducting the program
itemized, well-justified and consistent with planned program
activities?
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by the National
Center for HIV, STD, and TB Prevention (NCHSTP). Incomplete
applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above. Applications will be funded in order by score and rank
determined by the review panel. All persons serving on the panel will
be external to NCHSTP. CDC will provide justification for any decision
to fund out of rank order.
V.3. Anticipated Announcement and Award Dates
July 1, 2005.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the
CDC Procurement and Grants Office. The NoA shall be the only binding,
authorizing document between the recipient and CDC. The NoA will be
signed by an authorized Grants Management Officer, and mailed to the
recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: https://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions
AR-6 Patient Care
AR-10 Smoke-Free Workplace Requirements
AR-12 Lobbying Restrictions
AR-15 Proof of Non-Profit Status
AR-25 Release and Sharing of Data
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: https://www.cdc.gov/od/
pgo/funding/ARs.htm.
An additional Certifications form from the PHS 5161-1 application
needs to be included in your Grants.gov electronic submission only.
Refer to https://www.cdc.gov/od/pgo/funding/PHS5161-1Certificates.pdf.
Once the form is filled out, attach it to your Grants.gov submission as
Other Attachment Forms.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, due no less than 90 days before the end
of the budget period. The progress report will serve as your non-
competing continuation application, and must contain the following
elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Measures of Effectiveness.
f. Additional Requested Information.
2. Annual progress report, due 30 days after the end of the budget
period.
[[Page 22875]]
3. Financial status report, due no more than 90 days after the end
of the budget period.
4. Final financial and performance reports, due no more than 90
days after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement.
For general questions, contact: Technical Information Management
Section, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341, Telephone: 770-488-2700.
For program technical assistance, contact: Mary Wettrich, Project
Officer, HHS/CDC Global AIDS Program, 9300 Pretoria Place, Washington,
DC 20521-9300, Telephone: 27 12 346 0170, E-mail:
wettrichm@sacdc.co.za.
For financial, grants management, or budget assistance, contact:
Shirley Wynn, Contract Specialist, CDC Procurement and Grants Office,
2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-1515, E-
mail: zbx6@cdc.gov.
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC Web site, Internet address: https://www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: April 26, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-8751 Filed 5-2-05; 8:45 am]
BILLING CODE 4163-18-P